Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03936530
What this trial is testing

Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer

Who this might be right for
Colorectal Neoplasm
Shanghai Minimally Invasive Surgery Center 432
Not applicableStudy completedNCT03504618
What this trial is testing

Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI

Who this might be right for
Colorectal Cancer
Hanoi Medical University 39
Testing effectiveness (Phase 2)Looking for participantsNCT06349590
What this trial is testing

Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery

Who this might be right for
Colorectal Cancer
University of Chicago 80
Early research (Phase 1)Study completedNCT01238939
What this trial is testing

Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

Who this might be right for
Advanced Solid TumorsMetastatic Colorectal Cancer
Nippon Kayaku Co., Ltd. 35
Large-scale testing (Phase 3)Study completedNCT00096967
What this trial is testing

Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Who this might be right for
Breast CancerColorectal CancerMetastases
Genentech, Inc. 100
Not applicableStudy completedNCT06199232
What this trial is testing

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Who this might be right for
Liver Metastasis Colon CancerctDNA GenotypeMSS+1 more
Peking University 47
Testing effectiveness (Phase 2)Study completedNCT00153998
What this trial is testing

Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

Who this might be right for
Colorectal CancerLiver Metastases
Technische Universität Dresden 135
Testing effectiveness (Phase 2)UnknownNCT05314101
What this trial is testing

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Who this might be right for
ImmunotherapyColorectal Cancer
Fujian Cancer Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Not applicableStudy completedNCT01053104
What this trial is testing

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Who this might be right for
Metastatic Colorectal CancerMetastatic Breast Cancer
University of Oxford 26
Testing effectiveness (Phase 2)Study completedNCT00806663
What this trial is testing

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerLiver Metastases
Central European Society for Anticancer Drug Research 22
Large-scale testing (Phase 3)Study completedNCT01550055
What this trial is testing

Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Zhangjiang Biotechnology Limited Company 512
Large-scale testing (Phase 3)Study completedNCT00677443
What this trial is testing

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Samsung Medical Center 344
Not applicableUnknownNCT06321640
What this trial is testing

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Who this might be right for
Breast CancerLung CancerMelanoma+5 more
European Institute of Oncology 265
Testing effectiveness (Phase 2)Study completedNCT00078468
What this trial is testing

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment

Who this might be right for
Colorectal Neoplasms
Pfizer 56
Testing effectiveness (Phase 2)Ended earlyNCT00102024
What this trial is testing

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal CancerMetastases
Biogen 30
Testing effectiveness (Phase 2)UnknownNCT05965817
What this trial is testing

Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN

Who this might be right for
Colorectal CancerLiver Metastasis Colon CancerImage
Leiden University Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT00931840
What this trial is testing

EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Enzon Pharmaceuticals, Inc. 220
Testing effectiveness (Phase 2)Study completedNCT01058655
What this trial is testing

RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer

Who this might be right for
Gastrointestinal Cancer
Dana-Farber Cancer Institute 56
Not applicableEnded earlyNCT03849950
What this trial is testing

Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

Who this might be right for
LymphomaLung CancerColo-rectal Cancer
University Health Network, Toronto 62
Next Page